WW International Inc (WGHTQ)

Currency in USD
0.307
+0.017(+5.87%)
Closed·
Showing WW International historical data. For real-time data please try another search
Day's Range
0.2700.335
52 wk Range
0.1171.860
Key Statistics
Prev. Close
0.29
Open
0.28
Day's Range
0.27-0.335
52 wk Range
0.117-1.86
Volume
2.22M
Average Volume (3m)
26.75M
1-Year Change
-75.44%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

WW International Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

WW International Inc Company Profile

WW International, Inc. provides weight management products and services in the United States, Germany, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes. The company also provides various digital subscription products to weight loss and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform, as well as allows members to inspire and support each other by sharing their experiences with other people on weight health journeys. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1963 and is headquartered in New York, New York.

WW International Inc Earnings Call Summary for Q3/2025

  • WW reported Q3 2025 revenue of $172 million, down 11% YoY, while clinical revenue grew 35% and behavioral revenue fell 16%, leading to a 5.87% stock rise to $0.307
  • The company's subscriber base shows contrasting trends with clinical subscribers increasing 60% YoY to 124,000, while behavioral subscribers declined 20% to 2.9 million
  • WW set full-year 2025 revenue guidance at $695-700 million and adjusted EBITDA of $145-150 million, with a strong 24.9% EBITDA margin in Q3
  • Strategic initiatives include partnerships with Amazon Pharmacy, Novocare, and LillyDirect to enhance medication access, plus a new menopause program and mobile app replatforming
  • CEO Tara Comonte emphasized an integrated approach combining clinical care with structured nutrition and accountability as the future of weight management
Last Updated: 06/11/2025, 16:50
Read Full Transcript

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-117.84 / 0.12
Revenue / Forecast
-203,640,000.00 / 177.60M
EPS Revisions
Last 90 days

WGHTQ Income Statement

People Also Watch

909.30
ASML
+5.70%
18.99
FLNC
+13.24%
0.2514
PCSA
+3.80%
0.497
AURE
+0.40%
0.173
IMG
-0.58%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.